SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/27/2019
Entire Document
 

Table of Contents
(continued)

 

Page

 

8.21   Dissolution of Borrower or any Subsidiary 44
8.22   Case Administration Procedures 44
8.23   Actions Contrary to the Agreement 45
8.24   Challenges. 45
8.25   Grant of Adequate Protection 45
8.26   Adequate Protection 45
8.27   Change of Venue 45
8.28   Sale Agreement 45
9.            RIGHTS AND REMEDIES 45
9.1   Rights and Remedies 45
9.2   Remedies Cumulative 46
10.          WAIVERS; INDEMNIFICATION 46
10.1   Demand; Protest; etc. 46
10.2   The Lender Group’s Liability for Collateral 46
10.3   Indemnification 46
11.           NOTICES 47
12.           CHOICE OF LAW AND VENUE; JURY TRIAL WAIVER; JUDICIAL REFERENCE PROVISION 48
13.           ASSIGNMENTS AND PARTICIPATIONS; SUCCESSORS 50
13.1   Assignments and Participations 50
13.2   Successors 53
14.          AMENDMENTS; WAIVERS 53
14.1   Amendments and Waivers 53
14.2   Replacement of Certain Lenders 54
14.3   No Waivers; Cumulative Remedies 55
15.          AGENT; THE LENDER GROUP 55
15.1   Appointment and Authorization of Agent 55
15.2   Delegation of Duties 56
15.3   Liability of Agent 56
15.4   Reliance by Agent 57
15.5   Notice of Default or Event of Default 57
15.6   Credit Decision 57
15.7   Costs and Expenses; Indemnification 58

 

 

-v-